Good morning, folks. Another day is on the way. You know what this means, of course. Meetings and deadlines and who-knows-what-else are piling up. Where to begin? Well, we always start with a delicious cup of stimulation - Wild Mountain Blueberry is our choice this time. Feel free to indulge. Meanwhile, here are some choice tidbits. Hope your day goes well and give us a shout if you run across anything fascinating or just plain curious...
Sanofi To Close UK Plant And Eliminate 450 Jobs (BBC News)
FTC Asks Roche For More Info On Illumina Bid (Reuters)
Glaxo To Raise US And UK Salaries By Three To Four Percent (Employee Benefits)
Former Merck Unit Develops First Hepatitis C Vaccine (Bloomberg News)
Dozen Pa Docs Probed For Antipsychotic Prescribing (Philadelphia Inquirer)
China Health Care Cost-Cutting Threatens Pharma Profits (Bloomberg News)
Bristol-Myers CEO Got A 27 Percent Pay Hike (Bloomberg News)
Regeneron Says Its Eye Drug Is Taking Roche Patients (Reuters)
Elan Banks $381M From Sale Of Alkermes Stake (Pharma Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr
5 Comments
May I observe that the Bloomberg piece makes CHINA sound like ... "US?"
"China vowed to extend drug-price cuts, rankling some of the country’s largest manufacturers, in an overhaul of its health-care system to trim the cost of caring for an aging population."
Perhaps the US and the People's Republic have more in common than we thought?
"Perhaps the US and the People’s Republic have more in common than we thought?"
both ruled by oligarchs with their boot on the neck of the working poor?
'cos you know everything ain't hunky dory when a mere 4% raise is news worth repeating.
OMG Harpy - don't hold back so much ... tell us what you REALLY think .... then again:
http://dilbert.com/2012-03-14
... perhaps it's already been said today?
IMO anybody that can turn BMS around from the mess made by Dolan et al deserves a raise.
"Perhaps the US and the People’s Republic have more in common than we thought?"
CHImerica, perhaps?
More threat to pharma: Bayer lost Nexavar patent in India...
The emerging markets will safe us! Or maybe not...